OVERLAND PARK, Kan., Oct. 16, 2016 -- Pets owners can participate in a new study to advance arthritis treatment in dogs. The 12-week study includes blood work, X-rays and a supply of a joint supplement after study completion at no additional cost to participating dog owners, reports Nall Hills Animal Hospital. Local dog owners with canines with arthritis are invited to participate to study the effectiveness of a specific joint supplement.
Like humans, dogs can experience significant pain and reduced mobility with the onset of arthritis. Studies such as this one, presented by the veterinarian team at Nall Hills Animal Hospital, provides additional understanding of potential treatment options. Dogs at any age, but especially senior pets, may benefit from this study.
Dog owners interested in participating in the study should be aware that candidates for the study must not be taking any corticosteroids or non-steroidal anti-inflammatories (NSAIDs); owners must have internet access and be able to visit the hospital weekly for up to 12 weeks. Participating dog owners can expect blood work and X-rays at the time of enrollment to measure the effectiveness of care, and a supply of a joint supplement after the end of the study.
Arthritis can occur in any of a dog’s joints. Osteoarthritis is a common type of arthritis and can occur due to aging, injury, overuse or an unstable joint. Some forms of arthritis, such as septic arthritis, are a result of a bacterial or fungal infection. There are a variety of arthritis treatments available, including supplements, medication, cartilage protective agents, acupuncture, pain medication and steroids to help pet owners support the needs of their dogs with arthritis.
“Area dog owners are invited to participate in our 12-week study on a joint supplement to treat arthritis in dogs,” said Dr. John Teeter, DVM. “Our purpose is to test the effectiveness of a joint supplement and we appreciate the participation of area dog owners and their pets. Your help can allow us to learn more about how to effectively and safely treat arthritis in your beloved pet and in other dogs with arthritic symptoms.”
Dr. John Teeter, Dr. Robin Goodyear and Dr. Melissa Minor of Nall Hills Animal Hospital serve pets and their owners in and around Overland Park. Pet owners can expect quality veterinary care for prevention and treatment. Their veterinarian team stresses proper home care to ensure a healthy life for pets and partners with pet owners to develop individual care plans. Veterinary services include pet exams, pet dental, laser surgery, end-of-life decisions for pets, grooming, flea and tick treatment, pet digital radiography and boarding.
Call (913) 808-3181 to learn more about participating in the 12-week study for dogs with arthritis or visit http://nallhillsanimalhospital.com/ for details.
Nall Hills Animal Hospital, (913) 808-3181


Anta Sports Expands Global Footprint With Strategic Puma Stake
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Washington Post Publisher Will Lewis Steps Down After Layoffs
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Rio Tinto Shares Hit Record High After Ending Glencore Merger Talks
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million 



